APA

van Berg A. A., Mooyer P. A., van Lenthe H., Stet E. H., De Abreu R. A., van Kuilenburg A. B. & van Gennip A. H. (19951121). The IMP dehydrogenase inhibitor mycophenolic acid antagonizes the CTP synthetase inhibitor 3-deazauridine in MOLT-3 human leukemia cells: a central role for phosphoribosyl pyrophosphate. : Biochemical pharmacology.

Chicago

van Berg A A, Mooyer P A, van Lenthe H, Stet E H, De Abreu R A, van Kuilenburg A B and van Gennip A H. 19951121. The IMP dehydrogenase inhibitor mycophenolic acid antagonizes the CTP synthetase inhibitor 3-deazauridine in MOLT-3 human leukemia cells: a central role for phosphoribosyl pyrophosphate. : Biochemical pharmacology.

Harvard

van Berg A. A., Mooyer P. A., van Lenthe H., Stet E. H., De Abreu R. A., van Kuilenburg A. B. and van Gennip A. H. (19951121). The IMP dehydrogenase inhibitor mycophenolic acid antagonizes the CTP synthetase inhibitor 3-deazauridine in MOLT-3 human leukemia cells: a central role for phosphoribosyl pyrophosphate. : Biochemical pharmacology.

MLA

van Berg A A, Mooyer P A, van Lenthe H, Stet E H, De Abreu R A, van Kuilenburg A B and van Gennip A H. The IMP dehydrogenase inhibitor mycophenolic acid antagonizes the CTP synthetase inhibitor 3-deazauridine in MOLT-3 human leukemia cells: a central role for phosphoribosyl pyrophosphate. : Biochemical pharmacology. 19951121.